Investing Profile

Timothy A. Springer

InvestorVC
Founder, Institute for Protein Innovation
Massachusetts
Photo of Timothy A. Springer, Angel
cb
Angel
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Cartesian Therapeutics
Post Ipo EquityJul 2024$130M
$130M
Seismic Therapeutic
Series BDec 2023$120M
Series AFeb 2022$100M
$220M
Co-investors: Andrew Hedin (Bessemer Venture Partners), Alan Crane (Polaris Partners)
Selecta Biosciences
Post Ipo EquityNov 2023$60M
Series BFeb 2009$15M
$150M
Co-investors: Carl Gordon (OrbiMed), Amir Nashat (Polaris Partners), Aymeric Sallin (NanoDimension), Doug Cole (Flagship Ventures)
Prenuvo
Series AOct 2022$70M
$70M
Co-investors: Sundeep Peechu (Felicis Ventures), Eric Schmidt (Innovation Endeavors), Tony Fadell (Future Shape), Anne Wojcicki
Tectonic Therapeutic
Series AApr 2021$80M
$210M
Co-investors: Terry McGuire (Polaris Partners), Stefan Vitorovic (Vida Ventures)
Morphic Therapeutic
Series BSep 2018$80M
Series AJun 2016$52M
SeedJan 2016$3M
$140M
Co-investors: Vikas Goyal (SR One), Kevin Bitterman (Atlas Venture)
Scholar Rock
Series CJan 2018$47M
Series BJan 2016$36M
$310M
Co-investors: Amir Nashat (Polaris Partners)
Founder Institute for Protein Innovation2017 - Present
Professor Of Medicine Boston Children's Hospital2011 - Present
Latham Family Professor Harvard Medical School1989 - Present